Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AC
- Chemical substanceL04AC01Daclizumab
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 3 medicines · Historical list
United States
FDA · 3 medicines
European Union



